Company: SUPN
Filing Date: 2025-11-06
Form Type: 10-Q
Source: 0001356576-25-000071
Chunk: 222

Company: SUPERNUS PHARMACEUTICALS, INC.
Filing Date: 2025-11-06
Form: 10-Q
Item: Part I, Item 8
Chunk 222
---
 of revenues, research and development expenses, or selling, general and administrative expenses, in the condensed consolidated statements of earnings, depending on the nature of the activity.

32

To record its proportionate share of collaboration revenue from Biogen’s sales of ZURZUVAE to customers in the U.S., the Company utilizes certain information from Biogen, including revenue from the sale of the product and associated reserves on revenue. The following table summarizes the Company’s proportionate share of the activity under the Biogen Collaboration Agreement:Three Months EndedSeptember 30,Nine Months EndedSeptember 30,20252025(unaudited)Collaboration revenue (ZURZUVAE)$20,164 $20,164 Cost of revenues434 434 Research and development expenses(928)(928)Selling, general and administrative expenses13,561 13,561 

Amounts receivable from Biogen related to the Biogen Collaboration Agreement are recorded within Accounts receivable, net on the condensed consolidated balance sheets and were $19.9 million as of September 30, 2025. There were no amounts receivable from Biogen as of December 31, 2024. 

16.    Composition of Other Balance Sheet Items

The following details the composition of other balance sheet items (dollars in thousands for amounts in tables):

Inventories, Net September 30,2025December 31,2024(unaudited)Raw materials$56,988 $11,127 Work in process33,407 26,725 Finished goods16,705 16,441 Total$107,100 $54,293 Inventories, net as reported on the condensed consolidated balance sheets are as follows (dollars in thousands):Balance Sheet ClassificationSeptember 30, 2025December 31, 2024(unaudited)Current inventoryInventories, net$79,399 $54,293 Noncurrent inventoryOther Assets27,701 — Total $107,100 $54,293 

 Property and Equipment, Net 

33

September 30,2025December 31,2024(unaudited)Lab equipment and furniture$13,916 $13,370 Leasehold improvements14,024 14,023 Software883 883 Computer equipment1,264 1,112 Subtotal30,087 29,388 Less accumulated depreciation and amortization(19,460)(17,